Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04380805
Title A Study of AK104, a PD-1/CTLA-4 Bispecific Antibody in Subjects With Recurrent/Metastatic Cervical Cancer
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Akeso
Indications

cervical squamous cell carcinoma

cervical adenosquamous carcinoma

Therapies

AK104

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.